Long-term results of breast cancer treatment in the elderly and old age

The relapse-free and overall survival, after the treatment of breast cancer, in elderly and senile patients, in addition to the time of initial treatment and the stage of the disease, directly depends on the method and extent of treatment. The article reflects the results of a retrospective and prospective analysis of relapse-free and overall survival in 177 elderly and elderly patients who received treatment for breast cancer from 2005 to 2019. The number of elderly patients (from 60 to 74 years old inclusive) was 131 (74%), senile age (from 75 to 90 years old) - 46 (26%). The majority of patients with a histologically established clinical diagnosis of breast cancer, compiled stage II - 102 (57.6%), stage III - 58 (32.8%), stage IV - 14 (7.9%) and stage I - 3 (1.7%). According to the results of the study, established by the Kaplan Meier method, the relapse-free and overall 5-year survival rate was significantly lower in patients to whom monotherapy was used, which was 87.5% and 76.4% compared with the combined treatment (surgical treatment + postoperative radiation therapy) 100% and 82.5%, as well as in comparison with complex treatment (surgical treatment + postoperative chemotherapy + postoperative radiation therapy) 90.8% and 80%, respectively. As for the volume of surgical intervention, overall survival and disease-free survival is higher with radical removal of the mammary gland with regional fiber.